1. Home
  2. RAVE vs MIRA Comparison

RAVE vs MIRA Comparison

Compare RAVE & MIRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rave Restaurant Group Inc.

RAVE

Rave Restaurant Group Inc.

N/A

Current Price

$2.07

Market Cap

30.7M

ML Signal

N/A

Logo MIRA Pharmaceuticals Inc.

MIRA

MIRA Pharmaceuticals Inc.

N/A

Current Price

$0.36

Market Cap

26.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RAVE
MIRA
Founded
1958
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
30.7M
26.0M
IPO Year
1995
2023

Fundamental Metrics

Financial Performance
Metric
RAVE
MIRA
Price
$2.07
$0.36
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
★ $5.75
AVG Volume (30 Days)
33.5K
★ 134.1K
Earning Date
11-09-2026
12-01-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 5.26
N/A
EPS
★ 0.05
N/A
Revenue
★ $15,120,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$41.40
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$2.00
$0.33
52 Week High
$3.60
$1.69

Technical Indicators

Market Signals
Indicator
RAVE
MIRA
Relative Strength Index (RSI) 39.03 25.88
Support Level N/A N/A
Resistance Level $2.28 $0.82
Average True Range (ATR) 0.10 0.07
MACD 0.01 -0.00
Stochastic Oscillator 25.05 10.96

Price Performance

Historical Comparison
RAVE
MIRA

About RAVE Rave Restaurant Group Inc.

Rave Restaurant Group Inc operates and franchises pizza buffet, delivery/carry-out, express restaurants, and ghost kitchens. It operates restaurants under the brand names Pizza Inn and Pie Five Pizza Company. It has three operating segments. The Pizza Inn Franchising and Pie Five Franchising segments establish franchisees, licensees, and territorial rights. The corporate administration and other segments. The Pizza Inn Franchising segment accounts for the majority of the company's revenue. Geographically, it generates the majority of the revenue from the United States.

About MIRA MIRA Pharmaceuticals Inc.

Mira Pharmaceuticals Inc is a clinical-stage pharmaceutical development company focused on developing novel oral small-molecule therapeutics for neurologic, neuropsychiatric, metabolic, and inflammatory disorders. The company's pipeline includes three product candidates: Ketamir-2, MIRA-55, and SKNY-1, three drug candidates designed to address unmet medical needs across neuropathic and inflammatory pain, central nervous system disorders, and metabolic and behavioral conditions. The company operates as a single operating and reportable segment.

Share on Social Networks: